is being presented by Kattina V. Barsik, Esq. Intellectual Property and Registered Patent Attorney and airs on Tuesday, February 14th, 2012. For more details, or to register please visit our site at www.fxconferences.com
Institutions involved in the exchange of unique materials – including federal laboratories, industrial research laboratories, and laboratories in universities, hospitals, or independent research institutes – often have specific expectations regarding compensation for the help they provide. It may range from acknowledgment in a publication to ownership of inventions made with the aid of the provided material.
Industry defends its commercial interests vigorously, and seeks to offset risk by acquiring and protecting exclusivity in the marketplace through patent law or by use of trade secrets. In contrast, the federal government and its academic grantees look to preserve the flow of ideas for public benefit, primarily through timely publication, and to serve as the public's steward of inventions by preserving the potential for new knowledge to generate a product from which the public may benefit. The exchange of materials between universities and industrial laboratories is often difficult, and unlikely to be standardized in the near future.
This audio conference presentation discusses how to deal with these competing priorities, and craft terms which avoid conflict and allow all parties to benefit.
Showing posts with label patent. Show all posts
Showing posts with label patent. Show all posts
Thursday, January 26, 2012
Tuesday, May 24, 2011
Re-examinations, Litigation, and Other Mechanisms for Addressing “Problem” Patents
is being presented by Kevin McCabe & Dr. Eldora Ellison, Directors, Biotechnology/Chemical and Litigation Groups Sterne, Kessler, Goldstein & Fox P.L.L.C. and airs on Tuesday, June 7th, 2011. For more details, or to register please visit our site at www.fxconferences.com
Sooner or later, nearly all high technology companies encounter one or more patents that may present a roadblock to bringing a product to market or to conducting important research.
This audio conference presentation provides an overview of the legal tools available in the United States to help address such “problem” patents. In particular, our speakers provide a detailed discussion of patent re-examinations and the interplay between re-examinations and litigation. Additionally, the presentation looks at other mechanisms that may be used when one encounters a problematic patent, such as licensing, design-arounds, protests, interferences, and arbitration.
This presentation is informative both for companies that are concerned with patents held by others, as well as companies that may seek to enforce their own patents and thus subject such patents to validity challenges. The knowledge of these tools, and their various pros and cons, provided through this presentation give companies needed information to assist their strategic decision-making.
Sooner or later, nearly all high technology companies encounter one or more patents that may present a roadblock to bringing a product to market or to conducting important research.
This audio conference presentation provides an overview of the legal tools available in the United States to help address such “problem” patents. In particular, our speakers provide a detailed discussion of patent re-examinations and the interplay between re-examinations and litigation. Additionally, the presentation looks at other mechanisms that may be used when one encounters a problematic patent, such as licensing, design-arounds, protests, interferences, and arbitration.
This presentation is informative both for companies that are concerned with patents held by others, as well as companies that may seek to enforce their own patents and thus subject such patents to validity challenges. The knowledge of these tools, and their various pros and cons, provided through this presentation give companies needed information to assist their strategic decision-making.
Monday, January 18, 2010
Patent Portfolio Strategies in the Post-KSR Environment
Essential information for legal counsel and product development teams!
The Supreme Court’s decision in KSR v. Teleflex profoundly changed the landscape for biopharma companies and medical device manufacturers when it comes to building patent portfolios and managing them. More recently, the Federal Circuit’s Bilski decision in October 2008 added yet another dimension of complexity.
In this audio conference, we examine how this new environment changes the work of managers and professionals in product development teams, as well as patent professionals seeking to protect innovations. The presentation looks at how to identify and strengthen patents that might be vulnerable to obviousness attacks, and discusses ways to write and prosecute them to mitigate that risk.
Patent Portfolio Strategies in the Post-KSR Environment was presented by Bruce D. Sunstein, Co-Founder & Partner, Bromberg & Sunstein LLP and aired on 2009-02-12. For more details or to download this event, please visit our site at www.fxconferences.com
The Supreme Court’s decision in KSR v. Teleflex profoundly changed the landscape for biopharma companies and medical device manufacturers when it comes to building patent portfolios and managing them. More recently, the Federal Circuit’s Bilski decision in October 2008 added yet another dimension of complexity.
In this audio conference, we examine how this new environment changes the work of managers and professionals in product development teams, as well as patent professionals seeking to protect innovations. The presentation looks at how to identify and strengthen patents that might be vulnerable to obviousness attacks, and discusses ways to write and prosecute them to mitigate that risk.
Patent Portfolio Strategies in the Post-KSR Environment was presented by Bruce D. Sunstein, Co-Founder & Partner, Bromberg & Sunstein LLP and aired on 2009-02-12. For more details or to download this event, please visit our site at www.fxconferences.com
Tuesday, June 9, 2009
Effective Licensing in the Wake of MedImmune v. Genentech
The licensing of life science technologies, especially oncology-related technologies, is becoming an essential part of doing business. With MedImmune v. Genentech, the United States Supreme Court transformed the relationship between patent licensors and licensees. Historically, licensees were prevented from challenging patents on invalidity grounds. Now, a licensee may challenge a patent's validity while paying royalties to the licensor.
Although framed as a procedural question of standing to bring suit, the application of this Supreme Court case has the potential to shift the decision making of licensors and licensees and to significantly change the volume and cost of patent licensing activities. In this audio conference Dr. Samardija explores the Supreme Court decision and the various decisions that have followed, and provides attendees with 10 drafting tips to decrease the risks associated with a licensee challenging the validity of a patent.
Effective Licensing in the Wake of MedImmune v. Genentech was presented by Michael R. Samardzija, PhD, with Bracewell & Giuliani and aired on 2009-01-29. For more details or to download this conference, please visit our site at www.fxconferences.com
Although framed as a procedural question of standing to bring suit, the application of this Supreme Court case has the potential to shift the decision making of licensors and licensees and to significantly change the volume and cost of patent licensing activities. In this audio conference Dr. Samardija explores the Supreme Court decision and the various decisions that have followed, and provides attendees with 10 drafting tips to decrease the risks associated with a licensee challenging the validity of a patent.
Effective Licensing in the Wake of MedImmune v. Genentech was presented by Michael R. Samardzija, PhD, with Bracewell & Giuliani and aired on 2009-01-29. For more details or to download this conference, please visit our site at www.fxconferences.com
Monday, March 16, 2009
Global Patent Standards
Is your patent adequately protected in all of the markets where you do business? Are you sure about that?
In many industries, patent protection in both the United States and abroad is critical, but the requirements for each country are not necessarily the same. Thus, in developing a patent strategy, the different requirements of countries where protection is desired must be considered prior to filing.
In this audio conference, we review the various global patent standards in countries where patent protection is typically sought. Particular emphasis will be placed on written description requirements, obviousness and inventive step standards in the United States and in Europe.
Global Patent Standards is being presented by Christopher Rhodes, PhD, Intellectual Property Attorney, with JD - Lowrie Lando & Anastasi LLP and airs on Tuesday, March 24, 2009. For more details or to register for this conference, please visit our site www.fxconferences.com
In many industries, patent protection in both the United States and abroad is critical, but the requirements for each country are not necessarily the same. Thus, in developing a patent strategy, the different requirements of countries where protection is desired must be considered prior to filing.
In this audio conference, we review the various global patent standards in countries where patent protection is typically sought. Particular emphasis will be placed on written description requirements, obviousness and inventive step standards in the United States and in Europe.
Global Patent Standards is being presented by Christopher Rhodes, PhD, Intellectual Property Attorney, with JD - Lowrie Lando & Anastasi LLP and airs on Tuesday, March 24, 2009. For more details or to register for this conference, please visit our site www.fxconferences.com
Wednesday, January 21, 2009
Global Patent Standards
Is your patent adequately protected in all of the markets where you do business? Are you sure about that?
In many industries, patent protection in both the United States and abroad is critical, but the requirements for each country are not necessarily the same. Thus, in developing a patent strategy, the different requirements of countries where protection is desired must be considered prior to filing.
In this audio conference, we review the various global patent standards in countries where patent protection is typically sought. Particular emphasis will be placed on written description requirements, obviousness and inventive step standards in the United States and in Europe.
Global Patent Standards is being presented by Christopher Rhodes, PhD, Intellectual Property Attorney, with Lowrie Lando & Anastasi LLP and airs Tuesday, March 24, 2009. For more details or to register for this event, please visit our site at www.fxconferences.com
In many industries, patent protection in both the United States and abroad is critical, but the requirements for each country are not necessarily the same. Thus, in developing a patent strategy, the different requirements of countries where protection is desired must be considered prior to filing.
In this audio conference, we review the various global patent standards in countries where patent protection is typically sought. Particular emphasis will be placed on written description requirements, obviousness and inventive step standards in the United States and in Europe.
Global Patent Standards is being presented by Christopher Rhodes, PhD, Intellectual Property Attorney, with Lowrie Lando & Anastasi LLP and airs Tuesday, March 24, 2009. For more details or to register for this event, please visit our site at www.fxconferences.com
Friday, January 9, 2009
Patent Portfolio Strategies in the Post-KSR Environment
Essential information for legal counsel and product development teams!
The Supreme Court’s decision in KSR v. Teleflex profoundly changed the landscape for biopharma companies and medical device manufacturers when it comes to building patent portfolios and managing them. More recently, the Federal Circuit’s Bilski decision in October 2008 added yet another dimension of complexity.
In this audio conference, we examine how this new environment changes the work of managers and professionals in product development teams, as well as patent professionals seeking to protect innovations. The presentation looks at how to identify and strengthen patents that might be vulnerable to obviousness attacks, and discusses ways to write and prosecute them to mitigate that risk.
Patent Portfolio Strategies in the Post-KSR Environment is being presented by Bruce D. Sunstein, Co-founder and Partner, with Bromberg & Sunstein LLP and airs on Thursday, February 12, 2009. For more details on this conference or to register, please visit our site www.fxconferences.com
The Supreme Court’s decision in KSR v. Teleflex profoundly changed the landscape for biopharma companies and medical device manufacturers when it comes to building patent portfolios and managing them. More recently, the Federal Circuit’s Bilski decision in October 2008 added yet another dimension of complexity.
In this audio conference, we examine how this new environment changes the work of managers and professionals in product development teams, as well as patent professionals seeking to protect innovations. The presentation looks at how to identify and strengthen patents that might be vulnerable to obviousness attacks, and discusses ways to write and prosecute them to mitigate that risk.
Patent Portfolio Strategies in the Post-KSR Environment is being presented by Bruce D. Sunstein, Co-founder and Partner, with Bromberg & Sunstein LLP and airs on Thursday, February 12, 2009. For more details on this conference or to register, please visit our site www.fxconferences.com
Tuesday, December 9, 2008
Effective Licensing in the Wake of MedImmune v. Genentech
The licensing of life science technologies, especially oncology-related technologies, is becoming an essential part of doing business. With MedImmune v. Genentech, the United States Supreme Court transformed the relationship between patent licensors and licensees. Historically, licensees were prevented from challenging patents on invalidity grounds. Now, a licensee may challenge a patent's validity while paying royalties to the licensor.
Although framed as a procedural question of standing to bring suit, the application of this Supreme Court case has the potential to shift the decision making of licensors and licensees and to significantly change the volume and cost of patent licensing activities. In this audio conference Dr. Samardija explores the Supreme Court decision and the various decisions that have followed, and provides attendees with 10 drafting tips to decrease the risks associated with a licensee challenging the validity of a patent.
Effective Licensing in the Wake of MedImmune v. Genentech is being presented by Michael R. Samardzija, PhD, with Bracewell & Giuliani and airs on Thursday, January 29, 2009. For more details, or to register for this conference please visit our web site at www.fxconferences.com
Although framed as a procedural question of standing to bring suit, the application of this Supreme Court case has the potential to shift the decision making of licensors and licensees and to significantly change the volume and cost of patent licensing activities. In this audio conference Dr. Samardija explores the Supreme Court decision and the various decisions that have followed, and provides attendees with 10 drafting tips to decrease the risks associated with a licensee challenging the validity of a patent.
Effective Licensing in the Wake of MedImmune v. Genentech is being presented by Michael R. Samardzija, PhD, with Bracewell & Giuliani and airs on Thursday, January 29, 2009. For more details, or to register for this conference please visit our web site at www.fxconferences.com
Monday, December 8, 2008
Global Patent Standards
Is your patent adequately protected in all of the markets where you do business? Are you sure about that?
In many industries, patent protection in both the United States and abroad is critical, but the requirements for each country are not necessarily the same. Thus, in developing a patent strategy, the different requirements of countries where protection is desired must be considered prior to filing.
In this audio conference, we review the various global patent standards in countries where patent protection is typically sought. Particular emphasis will be placed on written description requirements, obviousness and inventive step standards in the United States and in Europe.
Global Patent Standards is being presented by Christopher Rhodes, PhD, JD, Intellectual Property Attorney, with Lowrie Lando & Anastasi LLP and airs on Thursday, January 15, 2009. For more details or to register for this event, please visit our site www.fxconferences.com
In many industries, patent protection in both the United States and abroad is critical, but the requirements for each country are not necessarily the same. Thus, in developing a patent strategy, the different requirements of countries where protection is desired must be considered prior to filing.
In this audio conference, we review the various global patent standards in countries where patent protection is typically sought. Particular emphasis will be placed on written description requirements, obviousness and inventive step standards in the United States and in Europe.
Global Patent Standards is being presented by Christopher Rhodes, PhD, JD, Intellectual Property Attorney, with Lowrie Lando & Anastasi LLP and airs on Thursday, January 15, 2009. For more details or to register for this event, please visit our site www.fxconferences.com
Subscribe to:
Posts (Atom)